| Grade 2 Follicular Lymphoma investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 77show all (up to 200) |
|---|
| → investigated in trials for | Rituximabmonoclonal antibody 39 trials (5 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 39 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall molecule 25 trials (0 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 25 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cyclophosphamidesmall molecule 19 trials (1 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 19 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenalidomidesmall molecule 15 trials (3 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bortezomibsmall molecule 11 trials (0 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Etoposidesmall molecule 10 trials (0 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ibrutinibsmall molecule 10 trials (4 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Filgrastimother 9 trials (1 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Obinutuzumabmonoclonal antibody 9 trials (5 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vorinostatsmall molecule 8 trials (1 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bendamustinesmall molecule 7 trials (2 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Busulfansmall molecule 7 trials (0 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Melphalansmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tanespimycinsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Venetoclaxsmall molecule 5 trials (3 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 5 | Observed | clinicaltrials | graph → |